A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 …
M Rodríguez Rubio, D Acuña Castroviejo… - 2020 - digibug.ugr.es
Objectives:• Primary objective: to evaluate the effect of intravenous melatonin (IVM) on
mortality in adult patients admitted to the intensive care unit (ICU) with COVID-19.• …
mortality in adult patients admitted to the intensive care unit (ICU) with COVID-19.• …
A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 …
M Rodríguez-Rubio, JC Figueira, D Acuña-Castroviejo… - Trials, 2020 - europepmc.org
• Primary objective: to evaluate the effect of intravenous melatonin (IVM) on mortality in adult
patients admitted to the intensive care unit (ICU) with COVID-19.• Secondary objectives:◦ To …
patients admitted to the intensive care unit (ICU) with COVID-19.• Secondary objectives:◦ To …
[引用][C] A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 …
M Rodríguez-Rubio, JC Figueira… - Trials, 2020 - portalcientifico.uned.es
A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the
efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive …
efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive …
[引用][C] A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 …
M Rodríguez-Rubio, JC Figueira, D Acuña-Castroviejo… - Trials, 2020 - repositorio.uam.es
A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the
efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the …
efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the …
A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 …
M Rodríguez-Rubio, JC Figueira, D Acuña-Castroviejo… - Trials, 2020 - search.proquest.com
A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy
and safety of intravenous m Page 1 LETTER Open Access A phase II, single-center, double-blind …
and safety of intravenous m Page 1 LETTER Open Access A phase II, single-center, double-blind …
A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 …
M Rodríguez-Rubio, JC Figueira… - Trials, 2020 - pubmed.ncbi.nlm.nih.gov
Objectives• Primary objective: to evaluate the effect of intravenous melatonin (IVM) on
mortality in adult patients admitted to the intensive care unit (ICU) with COVID-19.• …
mortality in adult patients admitted to the intensive care unit (ICU) with COVID-19.• …
[引用][C] A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 …
M Rodríguez-Rubio, JC Figueira… - …, 2020 - trialsjournal.biomedcentral.com
• Primary objective: to evaluate the effect of intravenous melatonin (IVM) on mortality in adult
patients admitted to the intensive care unit (ICU) with COVID-19.• Secondary objectives:◦ To …
patients admitted to the intensive care unit (ICU) with COVID-19.• Secondary objectives:◦ To …
A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 …
M Rodríguez-Rubio, JC Figueira, D Acuña-Castroviejo… - Trials, 2020 - ncbi.nlm.nih.gov
A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the
efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive …
efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive …
A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 …
M Rodríguez-Rubio, JC Figueira, D Acuéa-Castroviejo… - Trials, 2020 - go.gale.com
A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the
efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive …
efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive …
A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 …
M Rodríguez-Rubio, JC Figueira… - Trials, 2020 - search.ebscohost.com
Abstract < bold> Objectives: </bold>• Primary objective: to evaluate the effect of
intravenous melatonin (IVM) on mortality in adult patients admitted to the intensive care unit …
intravenous melatonin (IVM) on mortality in adult patients admitted to the intensive care unit …